CN113975653B - Phototherapy device for alleviating vitiligo symptoms - Google Patents
Phototherapy device for alleviating vitiligo symptoms Download PDFInfo
- Publication number
- CN113975653B CN113975653B CN202111494379.2A CN202111494379A CN113975653B CN 113975653 B CN113975653 B CN 113975653B CN 202111494379 A CN202111494379 A CN 202111494379A CN 113975653 B CN113975653 B CN 113975653B
- Authority
- CN
- China
- Prior art keywords
- cavity
- phototherapy
- spreading
- lead
- vitiligo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001126 phototherapy Methods 0.000 title claims abstract description 110
- 206010047642 Vitiligo Diseases 0.000 title claims abstract description 33
- 208000024891 symptom Diseases 0.000 title claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 56
- 230000007480 spreading Effects 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 39
- 238000002955 isolation Methods 0.000 claims abstract description 37
- 239000000758 substrate Substances 0.000 claims abstract description 21
- 238000001514 detection method Methods 0.000 claims description 20
- 238000009792 diffusion process Methods 0.000 claims description 20
- 239000003550 marker Substances 0.000 claims description 11
- 230000006835 compression Effects 0.000 claims description 7
- 238000007906 compression Methods 0.000 claims description 7
- 238000004804 winding Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 230000007246 mechanism Effects 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 238000013461 design Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000002752 melanocyte Anatomy 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000519995 Stachys sylvatica Species 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- LHQIJBMDNUYRAM-AWFVSMACSA-N D-erythro-biopterin Chemical compound N1=C(N)NC(=O)C2=NC([C@H](O)[C@H](O)C)=CN=C21 LHQIJBMDNUYRAM-AWFVSMACSA-N 0.000 description 1
- LHQIJBMDNUYRAM-UHFFFAOYSA-N L-erythro-Biopterin Natural products N1=C(N)NC(=O)C2=NC(C(O)C(O)C)=CN=C21 LHQIJBMDNUYRAM-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000004511 skin melanocyte Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
The application discloses a phototherapy device for alleviating vitiligo symptoms, comprising: a base; a first cavity is formed on the first side of the substrate, and a first phototherapy module is formed in the first cavity; two second cavities are further formed on the first side of the substrate, and the two second cavities are distributed on two sides of the first cavity; the second cavity is provided with a containing part capable of containing liquid medicine, and a transparent isolation part communicated with the containing parts respectively is arranged between the two containing parts; the transparent isolation part is laid on the first phototherapy module; and a spreading hole is arranged on one side of the transparent isolation layer, which is relatively far away from the first phototherapy module.
Description
Technical Field
The present disclosure relates generally to the field of phototherapy, and more particularly to phototherapy devices for alleviating vitiligo symptoms.
Background
Vitiligo is a common acquired pigment-deprived skin disease, and is manifested by limitation or ubiquity. It is common to treat the head and face, the extremities, the back side, the friction parts, and the skin and mucous membrane junction parts due to the loss of the skin melanocyte function or the decrease of the cell number. The etiology of the traditional Chinese medicine is not completely clear, and medicine treatment, pigment transplantation, phototherapy, decoloration treatment and the like can be given, and the treatment mainly relieves symptoms and can not thoroughly cure the white spots.
In recent decades, the incidence rate has an ascending trend, and the vitiligo does not endanger life, but seriously affects the beauty, and the abnormal eye light of people around the patient causes serious psychological burden to the patient, and affects job hunting and friend making. In the prior art, the ultraviolet laser achieves good curative effect in treating the localized vitiligo, and has the main advantages of less treatment times, but the adopted ultraviolet laser therapeutic apparatus has the problems of large volume, short service life, low efficiency, high-voltage excitation, inconvenient use and the like, and cannot perform large-area treatment, and the high energy of the ultraviolet laser therapeutic apparatus can cause certain damage to the skin and has certain side effects.
In order to solve the technical problems, patent ZL201610789719.7 also proposes an OLED vitiligo therapeutic apparatus, which uses an OLED as a therapeutic light source, adopts red light emitted by a red light emitting unit, and is matched with a repairing paste to effectively stimulate melanocytes to secrete melanin, so that the concentration level of hydrogen peroxide in vitiligo skin is reduced, and vitiligo is further treated. Although the technical scheme solves the technical problems to a certain extent, in practical application, the vitiligo treatment end cannot realize self-administration, and needs to be improved.
Disclosure of Invention
In view of the foregoing drawbacks or deficiencies of the prior art, it is desirable to provide a phototherapy device for alleviating the symptoms of vitiligo that is self-contained as compared to the prior art.
A phototherapy device for alleviating symptoms of vitiligo, comprising: a base; a first cavity is formed on the first side of the substrate, and a first phototherapy module is formed in the first cavity; two second cavities are further formed on the first side of the substrate, and the two second cavities are distributed on two sides of the first cavity; the second cavity is provided with a containing part capable of containing liquid medicine, and a transparent isolation part communicated with the containing parts respectively is arranged between the two containing parts; the transparent isolation part is laid on the first phototherapy module; and a spreading hole is arranged on one side of the transparent isolation layer, which is relatively far away from the first phototherapy module.
According to the technical scheme provided by the embodiment of the application, the containing part is provided with an outlet, and the outlet is provided with a quantitative medicine feeding part; an inlet of the transparent isolation part is connected to the outlet of the quantitative administration part; the containing part is also provided with an injection port exposed outside the second cavity.
According to the technical scheme provided by the embodiment of the application, the transparent isolation part is internally provided with a first cavity; the first cavity includes: the dispersing cavity is arranged at two ends of the transparent isolation part and can be communicated with the accommodating part, and the dispersing cavity is positioned in the middle of the dispersing cavity and is communicated with the dispersing cavity; and a spreading hole is arranged at one side of the spreading cavity, which is relatively far away from the first phototherapy module.
According to the technical scheme provided by the embodiment of the application, the overflow cavity comprises: a liquid guiding part communicated with the accommodating part and a diffusion part communicated with the liquid guiding part; the diameter of the diffusion part is larger than that of the liquid guiding part.
According to the technical scheme provided by the embodiment of the application, the inner bottom of the spreading cavity is provided with an elastic compression part; and the elastic compression part is hollow and communicated with the diffusion part.
According to the technical scheme provided by the embodiment of the application, the area on the same side of the transparent isolation part as the spreading hole is also provided with a leakage-proof area which is annularly arranged at the outer circumference of the spreading cavity; the leak-proof area includes: the leakage-proof edge is annularly arranged on the circumference of the spreading cavity, and one side of the leakage-proof edge facing the spreading cavity is made of the same material as the spreading cavity; and an adsorption layer is arranged on one side of the leakage-proof edge, which is far away from the spreading cavity, of the bottom edge.
According to the technical scheme provided by the embodiment of the application, a first space is formed between the first phototherapy module and the circumferential side wall of the first cavity; an elastic telescopic part which is annularly arranged is arranged in the first space; the base body is provided with an adjusting part for adjusting the elastic telescopic part and a lead part for connecting the adjusting part and the elastic telescopic part; the rotating adjusting part can drive the lead part to pull the elastic telescopic part to shrink or expand.
According to the technical scheme provided by the embodiment of the application, a plurality of first lead channels are annularly arranged on the elastic telescopic part in an array manner; the substrate is provided with a second lead channel which is arranged corresponding to the first lead channel and communicated with the first lead channel; the other end of the second lead channel is exposed at the second side of the substrate; the lead portion includes: a lead wire which enters the first lead wire channel from the second lead wire channel and is connected with the inner edge of the elastic adjusting part; the adjusting section includes: and the winding and unwinding mechanism is positioned on the second side of the substrate and used for winding each lead in the second lead channel.
According to the technical scheme provided by the embodiment of the application, the first phototherapy module includes: at least one annular phototherapy unit concentrically disposed.
According to the technical scheme provided by the embodiment of the application, an elastic marking ring is arranged between the annular inner edges of the elastic telescopic parts; a detection sensor for detecting the marking ring is arranged between two adjacent phototherapy units; further comprises: and the control module is configured to drive the phototherapy unit corresponding to the marking ring to be closed when the detection sensor detects the marking ring.
In summary, the present application discloses a phototherapy device for alleviating vitiligo symptoms, wherein, on one hand, a first phototherapy module is embedded in a first cavity, and after the first phototherapy module is started, phototherapy can be performed on an affected part of a patient; on the other hand, second cavities are arranged on two sides of the first cavity, containing parts for containing liquid medicine are arranged in the two second cavities, and in addition, transparent isolation parts communicated with the containing parts are arranged between the two containing parts. Based on the design, the transparent isolation part is laid on the first phototherapy module; and a spreading hole is arranged on one side of the transparent isolation part, which is relatively far away from the first phototherapy module. When the device is used, the liquid medicine in the spreading holes can be coated on the affected part to be phototherapy. Based on the design and the application process, compared with the prior art, the device can add liquid medicine at any time in the use process and can realize better treatment effect by matching with the phototherapy effect when the device is coated and then phototherapy is implemented. In addition, the design of isolation layer can avoid the liquid medicine to contact with first phototherapy module, avoids polluting the base member for use experience is better.
Furthermore, the technical scheme also optimizes the internal structure of the transparent isolation part, and specifically, the first cavity is divided into a dispersing cavity at two ends and a spreading cavity in the two dispersing cavities. The design of the overflow cavity can play a primary drainage and dispersion role on the liquid medicine so as to ensure that the liquid medicine can cover the spreading cavity to the maximum extent and further uniformly overflow the spreading holes. Preferably, the technical scheme further optimizes the design of the overflow cavity, namely: dividing the overflow cavity into: the liquid guiding part is communicated with the accommodating part and is used for guiding the liquid; and a diffusion portion in communication with the liquid introduction portion, the diffusion portion having a diameter greater than a diameter of the liquid introduction portion.
Further, the technical scheme is that the side, relatively far away from the matrix, of the transparent isolation part is provided with the anti-drain region so as to prevent the liquid medicine from overflowing and spreading out of the spreading holes to the greatest extent, and ensure the cleaning effect in the use process.
Furthermore, the technical scheme also carries out optimal design on the structure of the first cavity, specifically, a first space is formed between the first phototherapy module and the circumferential side wall of the first cavity, and an annular elastic expansion part is arranged in the first space.
Drawings
Other features, objects and advantages of the present application will become more apparent upon reading of the detailed description of non-limiting embodiments, made with reference to the following drawings, in which:
fig. 1 is a schematic structure view of a phototherapy apparatus for alleviating the symptoms of vitiligo.
FIG. 2 is a schematic structural view of a phototherapy device for alleviating the symptoms of vitiligo (dosing);
FIG. 3 is a schematic view of a transparent spacer;
FIG. 4 is a schematic top view of a transparent spacer;
FIG. 5 is a schematic top view of a transparent spacer (elastic compression section);
FIG. 6 is a schematic structural view (leak-proof rim) of a phototherapy device for alleviating the symptoms of vitiligo;
fig. 7 is a schematic structural view (elastic expansion and contraction portion) of a phototherapy apparatus for alleviating vitiligo symptoms;
fig. 8 is a schematic structural view (lead) of a phototherapy apparatus for alleviating the symptoms of vitiligo;
fig. 9 is a schematic structural view of a phototherapy apparatus (elastic marker ring and phototherapy unit) for alleviating the symptoms of vitiligo.
Detailed Description
The present application is described in further detail below with reference to the drawings and examples. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention. It should be noted that, for convenience of description, only the portions related to the invention are shown in the drawings.
It should be noted that, in the case of no conflict, the embodiments and features in the embodiments may be combined with each other. The present application will be described in detail below with reference to the accompanying drawings in conjunction with embodiments.
Embodiment one:
please refer to the structural schematic diagram of a phototherapy device for alleviating vitiligo symptoms shown in fig. 1.
The phototherapy device for alleviating vitiligo symptoms includes:
a base body 10;
a first cavity 20 is formed on the first side of the base 10, and a first phototherapy module 21 is formed in the first cavity 20;
two second cavities 30 are further formed on the first side of the substrate 10, and the two second cavities 30 are distributed on two sides of the first cavity 20; the second cavity 30 is provided with a containing part 31 capable of containing the liquid medicine, and a transparent isolation part 40 respectively communicated with the containing parts 31 is arranged between the two containing parts 31;
the transparent isolation part 40 is laid on the first phototherapy module 21; and a spreading hole 41 is arranged at one side of the transparent isolation part 40 relatively far from the first phototherapy module 21.
Wherein:
along with the extensive research of free radical in medicine, the success of in vitro culture of melanocytes and the development of enzyme and enzyme activity detection technology, the research shows that certain enzyme activities in the free radical defense system of vitiligo patients are reduced, H2O2 in epidermis is aggregated, oxidative stress state is caused, the circulation of biopterin is interfered, certain enzyme activities are inhibited, the melanocytes are directly or indirectly damaged, and decolored white spots appear clinically.
Red light treatment is to filter most of the red light, mainly in the red band, and its biological effect is mainly photochemical, not thermal. The maximum absorption in the red region is considered by foreign scholars to be mitochondria, and the activity of catalase in mitochondria can be increased after red light irradiation. Catalase (CAT), an enzyme that catalyzes the decomposition of hydrogen peroxide into oxygen and water, reduces the H2O2 content in the epidermis, increases the enzymatic activity, and avoids damage to melanocytes.
In order to conveniently realize phototherapy on a patient area, the embodiment specifically provides a specific structure of a phototherapy device for alleviating vitiligo symptoms.
Wherein:
the substrate 10 is optionally made of a flexible material, and a first cavity is disposed on one side of the substrate, as shown in fig. 1, where the length direction of the substrate is set to be a first direction, and the width direction of the substrate is set to be a second direction. A first phototherapy module 21 is formed in the first cavity. Optionally, the substrate 10 has a strip-shaped structure, so as to enable the first phototherapy module 21 thereon to be attached to an affected part of a patient. Preferably, the first cavity is circular or rectangular in shape.
Two second cavities 30 are further formed on the first side of the substrate 10, and the two second cavities 30 are distributed on two sides of the first cavity 20. As shown in fig. 1, the second cavity may optionally extend in a second direction. Preferably, the second cavity is of a cylindrical structure.
And a receiving part 31 disposed in the second cavity, optionally, the receiving part 31 has a columnar structure and extends along the second direction, and spans in the second cavity. The accommodating part is internally provided with an accommodating cavity, the accommodating cavity is of a sealing structure and can accommodate liquid medicine, and specifically, the bottom of the accommodating cavity is provided with an outlet. Optionally, a one-way valve is arranged at the outlet of the accommodating cavity, so that the liquid medicine amount entering the transparent isolation part can be controlled conveniently.
And the transparent isolation part is arranged between the outlets of the two accommodating cavities. The transparent isolation part is internally provided with a transparent isolation cavity, and two ends of the transparent isolation part are respectively communicated with the outlet of the containing cavity, so that the interior of the isolation cavity is communicated with the containing cavity.
In the specific application scene, the first phototherapy module is just corresponding to the affected part of the patient first, and the two ends of the matrix are buckled with each other, and the specific buckling mode is not limited, for example: button, or magnetic button, or magic tape. The holding chamber (e.g., solenoid valve may also be actuated) is squeezed, the liquid medicine in the holding chamber enters the transparent isolation portion, and the liquid medicine in the spreading holes can be coated on the affected part to be phototherapy via the spreading Kong Yisan on the side of the transparent isolation layer relatively far away from the substrate.
Based on the design and the application process, compared with the prior art, the device can add liquid medicine at any time in the use process and can realize better treatment effect by matching with the phototherapy effect when the device is coated and then phototherapy is implemented. In addition, the design of isolation part can avoid the liquid medicine to contact with first phototherapy module, avoids polluting the base member for use experience is better.
Alternatively, an outlet is provided on the accommodating portion 31 and a dosing portion 32 is provided at the outlet; an inlet of the transparent partition 40 is connected to an outlet of the dosing section 32; the receiving portion 31 is further provided with an injection port exposed outside the second chamber 30. Specifically, the dosing portion 32 may be a solenoid valve. Specifically, in order to facilitate the filling of the liquid medicine into the accommodating portion 31, the accommodating portion 31 is further provided with an injection port exposed outside the second cavity 30, and as shown in fig. 2, the injection port is exposed on the second side of the substrate.
Embodiment two:
unlike the first embodiment, the transparent spacer is specifically designed optimally in this embodiment.
The transparent isolation portion 40 is provided with a first cavity 42 inside.
The first cavity 42 includes: the dispersing cavity 421 is arranged at two ends of the transparent isolation part 40 and can be communicated with the accommodating part 31, and the dispersing cavity 422 is positioned in the middle of the dispersing cavity 421 and is communicated with the dispersing cavity 421; the side of the spreading cavity 422, which is relatively far from the first phototherapy module 21, is provided with a spreading hole 41.
In fig. 3, the first cavity is divided into a spill cavity at both ends and a dressing cavity in both spill cavities. The design of the overflow cavity can play a primary drainage and dispersion role on the liquid medicine so as to ensure that the liquid medicine can cover the spreading cavity to the maximum extent and further uniformly overflow the spreading holes.
In particular, the dispensing chamber is preferably circular or rectangular to accommodate the shape of the first phototherapy module.
Preferably, referring to fig. 4, the overflow cavity 421 includes: a liquid introduction portion 423 communicating with the accommodating portion 31 and a diffusion portion 424 communicating with the liquid introduction portion 423; the diameter of the diffusion portion 424 is larger than the diameter of the liquid introduction portion 423.
The technical scheme further optimizes the design of the overflow cavity, namely: dividing the overflow cavity into: the liquid guiding part is communicated with the accommodating part and is used for guiding the liquid; and a diffusion section communicating with the liquid introduction section. The liquid medicine enters the diffusion part from the liquid guiding part, and the liquid medicine entering the diffusion part can be fully diffused in the diffusion part because the diameter of the diffusion part is larger than that of the liquid guiding part, so that the liquid medicine can be ensured to uniformly enter the spreading cavity and uniformly overflow out of the spreading holes.
Specifically, the liquid-guiding portion is tapered in shape for gradually diffusing the liquid medicine.
Specifically, the diffusion part is in a semicircular structure, one end of the diffusion part is connected with one end of the liquid guiding part with larger diameter and is used for receiving the liquid medicine guided by the liquid guiding part, and the liquid medicine is diffused to the greatest extent and then enters the spreading cavity.
Optionally, an elastic compression portion 425 is provided at the bottom of the dispensing chamber 422; and the elastic compression portion 425 is hollow inside and communicates with the diffusion portion 424.
Referring to fig. 5, based on the above design, the liquid medicine enters the diffusion portion from the liquid guiding portion and then enters the elastic expansion portion.
On one hand, the elastic telescopic part is convenient for caching the liquid medicine, and the situation that the liquid medicine is released for a single time is avoided; on the other hand, the elastic expansion part can help the liquid medicine to be discharged under the self gravity of the elastic expansion part, and can be uniformly spread on the affected part of the patient under the pressure of the elastic expansion part.
Optionally, the elastic expansion part is an expansion joint structure with a columnar structure, is hollow in the interior and is communicated with the diffusion part.
Embodiment III:
the transparent isolation part 40 is also provided with a leakage-proof area which is annularly arranged at the outer circumference of the spreading cavity 422 in the area at the same side as the spreading hole 41; the leak-proof area includes: a leakage prevention edge 50 is circumferentially disposed around the dispensing chamber 422.
Referring to fig. 6, in particular, the leakage preventing edges are in an annular structure and are uniformly distributed along the circumferential direction of the spreading hole, and in particular, the side of the leakage preventing edge 50 facing the spreading cavity 422 is made of the same material as the spreading cavity 422, such as a silicone material; the leakage prevention is equipped with the adsorbed layer along one side of 50 bottom edges away from the scattering chamber 422, if: cotton layer or non-woven fabric layer.
Optionally, the longitudinal section of the leakage preventing edge is in a trapezoid structure.
In the concrete application scene, the leakage-proof edge inner wall can not influence the use of the liquid medicine in contact with the liquid medicine, but if the liquid medicine is scattered outwards, the adsorption layer can primarily adsorb the liquid medicine, and the liquid medicine is prevented from being scattered outwards of the area covered by the matrix.
Embodiment four:
a first space is formed between the first phototherapy module 21 and the circumferential side wall of the first cavity 20; an elastic telescopic part 60 which is annularly arranged is arranged in the first space; the base body 10 is provided with an adjusting part 70 for adjusting the elastic expansion part 60 and a lead part 80 for connecting the adjusting part 70 and the elastic expansion part 60; the rotation adjusting portion 70 can drive the wire portion 80 to pull the elastic expansion portion 60 to contract or expand.
Referring to fig. 7, the thickness of the first phototherapy module is lower than the height of the first cavity, so a first space is formed between the first phototherapy module and the inner wall of the first cavity.
The elastic telescopic part is of an annular structure, and the outer edge with a larger diameter on the elastic telescopic part is connected with the side wall of the first cavity.
In fig. 7, the base body further includes a lead portion having one end for connecting the elastic expansion portion and an adjusting portion connected to the other end of the lead portion.
When the adjusting portion 70 is not rotated, the adjusting portion is maintained in an initial state, and a length of the end of the lead portion connected to the adjusting portion wound around the adjusting portion is maximized, that is: the length of the lead wire portion connected to the elastic telescopic portion is shortest, at this time, the elastic telescopic portion is contracted to the maximum extent, and the area exposed by the inner edge of the elastic telescopic portion is the largest, namely: the second space is the largest, and the area of the first phototherapy module exposed through the second space is the largest.
When the adjusting portion 70 is rotated, the length of the end of the lead portion connected to the adjusting portion wound around the adjusting portion starts to change, that is: the length of the lead wire part connected to the elastic telescopic part is gradually increased, at this time, the elastic telescopic part is gradually unfolded, and the exposed area of the inner edge of the elastic telescopic part is gradually reduced, namely: the second space is gradually reduced, and the exposed area of the first phototherapy module penetrating through the second space is also gradually reduced.
Specifically, referring to fig. 8, a plurality of first lead channels 61 are disposed on the elastic expansion portion 60 in a ring array; the substrate 10 is provided with a second lead channel 11 which is arranged corresponding to the first lead channel 61 and is communicated with the first lead channel; the other end of the second lead channel 11 is exposed at the second side of the substrate 10; the lead portion 80 includes: a lead 81 which enters the first lead path 61 from the second lead path 11 and is connected to the inner edge of the elastic regulating portion 70; the adjusting part 70 includes: a winding and unwinding mechanism 71 on the second side of the base 10 for winding up the respective leads 81 in the second lead path 11.
A specific embodiment of the lead portion is given in fig. 8, namely: and a lead 81.
The adjusting part can be a retracting mechanism, such as a scroll.
Preferably, referring to fig. 9, the first phototherapy module 21 includes: at least one phototherapy unit 211 concentrically disposed. The phototherapy unit at the center is of a circular structure; the phototherapy units outside the central phototherapy unit are elliptical rings, and can be one or two or three or four or five.
An elastic marking ring 62 is arranged between the annular inner edges of the elastic telescopic parts 60; a detection sensor 22 for detecting the marker ring 62 is provided between two adjacent phototherapy units 211; further comprises: and a control module configured to drive the phototherapy unit 211 corresponding to the marker ring 62 to be turned off when the detection sensor 22 detects the marker ring 62.
Referring to fig. 9, the smaller diameter inner edge of the elastic expansion portion 60 is provided with an elastic marking ring 62, which is contracted or expanded along with the contraction or expansion of the elastic expansion portion.
Referring to fig. 9, a detection sensor 22 for detecting the marker ring 62 is provided between two adjacent phototherapy units 211; specifically, in fig. 9, three annular phototherapy units are provided, and at least two detection sensors 22 distributed in an annular array are provided between two adjacent phototherapy units. Specifically, the three annular phototherapy units include: a circular first phototherapy unit 211a located at the center, a third phototherapy unit 211c located at the outermost ring, and 211b located between the first phototherapy unit 211a and the third phototherapy unit 211 c.
The first detection sensor between the first phototherapy unit 211a and the second phototherapy unit 211b is 22b.
The second detection sensor between the second phototherapy unit 211b and the third phototherapy unit 211c is 22c
And a control module configured to drive the phototherapy unit 211 corresponding to the marker ring 62 to be turned off when the detection sensor 22 detects the marker ring 62.
The control module is internally provided with a corresponding relation between the detection sensor and the phototherapy unit, such as:
the second phototherapy unit 211b corresponds to the first detection sensor 22b.
The third phototherapy unit 211c corresponds to the second detection sensor 22 c.
When the first detection sensor 22b detects the marker ring 62, it indicates: the edge of the elastic telescopic part reaches the position of the first detector, at the moment, the elastic telescopic part shields the second phototherapy unit, and at the moment, the second phototherapy module and the third phototherapy unit are closed.
When the second detection sensor 22c detects the marker ring 62, it indicates that: the edge of the elastic telescopic part reaches the position of the second detector, and at the moment, the elastic telescopic part shields the third phototherapy unit, and at the moment, the third phototherapy unit is closed.
Similarly, when the number of phototherapy units is N, the number of detection sensors is N-1, specifically, the corresponding relation between the detection sensors N-1 and the phototherapy units N is set and stored in the control module.
When the detection sensor N-1 detects that the rings are marked, the control module turns off the phototherapy units except the phototherapy unit N.
Based on the design, the control module can correspondingly close the shielded phototherapy unit according to the shielded area of the elastic telescopic part, so that energy waste is avoided, and the use scene of the device is increased.
The foregoing description is only of the preferred embodiments of the present application and is presented as a description of the principles of the technology being utilized. It will be appreciated by persons skilled in the art that the scope of the invention referred to in this application is not limited to the specific combinations of features described above, but it is intended to cover other embodiments in which any combination of features described above or equivalents thereof is possible without departing from the spirit of the invention. Such as the above-described features and technical features having similar functions (but not limited to) disclosed in the present application are replaced with each other.
Claims (9)
1. A phototherapy device for relieving vitiligo symptoms is characterized in that,
comprising the following steps: a base body (10);
a first cavity (20) is formed on the first side of the base body (10), and a first phototherapy module (21) is formed in the first cavity (20);
two second cavities (30) are also formed on the first side of the substrate (10), and the two second cavities (30) are distributed on two sides of the first cavity (20); the second cavity (30) is provided with containing parts (31) capable of containing liquid medicine, and transparent isolating parts (40) respectively communicated with the containing parts (31) are arranged between the two containing parts (31);
the transparent isolation part (40) is laid on the first phototherapy module (21); and one side of the transparent isolation part (40) relatively far away from the first phototherapy module (21) is provided with a spreading hole (41);
a first cavity (42) is formed in the transparent isolation part (40);
the first cavity (42) comprises: a scattering cavity (421) which is arranged at two ends of the transparent isolation part (40) and can be communicated with the containing part (31), and a spreading cavity (422) which is positioned in the middle of the scattering cavity (421) and is communicated with the scattering cavity (421);
and a spreading hole (41) is arranged at one side of the spreading cavity (422) relatively far away from the first phototherapy module (21).
2. A phototherapy device for alleviating symptoms of vitiligo according to claim 1, wherein:
an outlet is formed in the accommodating part (31), and a quantitative administration part (32) is arranged at the outlet;
an inlet of a transparent isolation part (40) is connected to the outlet of the quantitative administration part (32);
the accommodating part (31) is also provided with an injection port exposed outside the second cavity (30).
3. Phototherapy device for alleviating symptoms of vitiligo according to claim 1 or 2, characterized in that:
the spill cavity (421) comprises: a liquid guiding part (423) communicated with the accommodating part (31) and a diffusion part (424) communicated with the liquid guiding part (423);
the diameter of the diffusion portion (424) is larger than the diameter of the liquid introduction portion (423).
4. A phototherapy device for alleviating symptoms of vitiligo as claimed in claim 3, wherein:
an elastic compression part (425) is arranged at the inner bottom of the spreading cavity (422); and the elastic compression part (425) is hollow inside and is communicated with the diffusion part (424).
5. Phototherapy device for alleviating symptoms of vitiligo according to claim 1 or 2, characterized in that:
the area on the same side of the transparent isolation part (40) as the spreading hole (41) is also provided with a leakage-proof area which is annularly arranged at the outer circumference of the spreading cavity (422);
the leak-proof area includes: the leakage-proof edge (50) is annularly arranged on the circumference of the spreading cavity (422), and one side of the leakage-proof edge (50) facing the spreading cavity (422) is made of the same material as the spreading cavity (422); an adsorption layer is arranged on one side of the bottom edge of the leakage-proof edge (50) far away from the spreading cavity (422).
6. Phototherapy device for alleviating symptoms of vitiligo according to claim 1 or 2, characterized in that:
a first space is formed between the first phototherapy module (21) and the circumferential side wall of the first cavity (20);
an elastic telescopic part (60) which is annularly arranged is arranged in the first space;
an adjusting part (70) for adjusting the elastic expansion part (60) and a lead part (80) for connecting the adjusting part (70) and the elastic expansion part (60) are arranged on the base body (10);
the rotation adjusting part (70) can drive the lead part (80) to pull the elastic telescopic part (60) to shrink or expand.
7. The phototherapy device for alleviating symptoms of vitiligo according to claim 6, wherein:
a plurality of first lead channels (61) are arranged on the elastic telescopic part (60) in an annular array manner;
the substrate (10) is provided with a second lead channel (11) which is arranged corresponding to the first lead channel (61) and communicated with each other; the other end of the second lead channel (11) is exposed on the second side of the substrate (10);
the lead portion (80) includes: a lead (81) which enters the first lead passage (61) from the second lead passage (11) and is connected to the inner edge of the elastic regulating portion (70);
the adjustment section (70) includes: and a winding and unwinding mechanism (71) located on the second side of the base body (10) for winding up each wire (81) in the second wire path (11).
8. The phototherapy device for alleviating symptoms of vitiligo according to claim 6, wherein:
the first phototherapy module (21) comprises: at least one annular phototherapy unit (211) arranged concentrically.
9. The phototherapy device for alleviating symptoms of vitiligo according to claim 8, wherein:
an elastic marking ring (62) is arranged between the annular inner edges of the elastic telescopic parts (60);
a detection sensor (22) for detecting the marking ring (62) is arranged between two adjacent phototherapy units (211);
further comprises: and a control module configured to drive the phototherapy unit (211) corresponding to the marker ring (62) to be turned off when the detection sensor (22) detects the marker ring (62).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111494379.2A CN113975653B (en) | 2021-12-08 | 2021-12-08 | Phototherapy device for alleviating vitiligo symptoms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111494379.2A CN113975653B (en) | 2021-12-08 | 2021-12-08 | Phototherapy device for alleviating vitiligo symptoms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113975653A CN113975653A (en) | 2022-01-28 |
| CN113975653B true CN113975653B (en) | 2024-01-26 |
Family
ID=79733523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111494379.2A Active CN113975653B (en) | 2021-12-08 | 2021-12-08 | Phototherapy device for alleviating vitiligo symptoms |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113975653B (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017006348A (en) * | 2015-06-22 | 2017-01-12 | コニカミノルタ株式会社 | Optical treatment apparatus |
| JP2017006347A (en) * | 2015-06-22 | 2017-01-12 | コニカミノルタ株式会社 | Optical treatment apparatus |
| CN109310527A (en) * | 2016-02-09 | 2019-02-05 | 鲁玛治疗公司 | For treating psoriasic method, composition and equipment by light therapy |
| KR102079818B1 (en) * | 2019-08-29 | 2020-02-20 | 주식회사 이스텍코리아 | drug infusion mothod and device of skin by laser |
| CN111481424A (en) * | 2019-11-29 | 2020-08-04 | 焦在华 | Equipment for promoting drug effect absorption through light irradiation |
| CN111840809A (en) * | 2020-07-22 | 2020-10-30 | 固安翌光科技有限公司 | Optical medical device |
| CN212547986U (en) * | 2020-04-02 | 2021-02-19 | 北京翌光科技有限公司 | Wearable phototherapy wound device and wound subassembly |
| CN213912001U (en) * | 2020-10-27 | 2021-08-10 | 上海市皮肤病医院 | Vitiligo traditional chinese medicine illumination machine convenient to carry |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7320801B2 (en) * | 2005-09-26 | 2008-01-22 | Jack Perez Kelly | Patch for treating symptoms of a skin abscess |
| US20160351038A1 (en) * | 2015-05-29 | 2016-12-01 | Midwest Business Associates, Inc. | System for medical device software alert hierarchy management |
| CA3158283A1 (en) * | 2019-10-21 | 2021-04-29 | Incando Therapeutics Pte. Ltd. | Methods and apparatus for phototherapy |
-
2021
- 2021-12-08 CN CN202111494379.2A patent/CN113975653B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017006348A (en) * | 2015-06-22 | 2017-01-12 | コニカミノルタ株式会社 | Optical treatment apparatus |
| JP2017006347A (en) * | 2015-06-22 | 2017-01-12 | コニカミノルタ株式会社 | Optical treatment apparatus |
| CN109310527A (en) * | 2016-02-09 | 2019-02-05 | 鲁玛治疗公司 | For treating psoriasic method, composition and equipment by light therapy |
| KR102079818B1 (en) * | 2019-08-29 | 2020-02-20 | 주식회사 이스텍코리아 | drug infusion mothod and device of skin by laser |
| CN111481424A (en) * | 2019-11-29 | 2020-08-04 | 焦在华 | Equipment for promoting drug effect absorption through light irradiation |
| CN212547986U (en) * | 2020-04-02 | 2021-02-19 | 北京翌光科技有限公司 | Wearable phototherapy wound device and wound subassembly |
| CN111840809A (en) * | 2020-07-22 | 2020-10-30 | 固安翌光科技有限公司 | Optical medical device |
| CN213912001U (en) * | 2020-10-27 | 2021-08-10 | 上海市皮肤病医院 | Vitiligo traditional chinese medicine illumination machine convenient to carry |
Non-Patent Citations (1)
| Title |
|---|
| 白癜风的光疗法;于潮;中国激光医学杂志(第6期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113975653A (en) | 2022-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8146607B2 (en) | Ventilated device for delivery of agents to and through the human scalp | |
| CN111050711B (en) | Anti-deformation wound treatment devices and related methods of use | |
| US20220126113A1 (en) | Portable rechargeable led red light cavity healing devices | |
| US20080065176A1 (en) | Vacuum and negative ions assisted phototheraphy device | |
| US11559622B2 (en) | Deformation resistant wound therapy apparatus and related methods of use | |
| EP2686066B1 (en) | Cartridge and medical apparatus | |
| WO2013187572A1 (en) | Self-injection mechanism for use on skin | |
| CN113975653B (en) | Phototherapy device for alleviating vitiligo symptoms | |
| CN101940817B (en) | Light-medicine-combined treatment device for skin ulcers | |
| WO2007124446A2 (en) | Device for delivery of agents to and through the human scalp | |
| CN201871130U (en) | Light and medicine combined skin ulcer treatment device | |
| CN212593032U (en) | Portable chronic wound surface hyperbaric oxygen therapeutic instrument | |
| KR20100005782U (en) | A cupping glass | |
| CN213406562U (en) | Negative pressure scar inhibition patch support | |
| KR200460107Y1 (en) | pas including T needle | |
| CN213219128U (en) | Use comfortable moxa-moxibustion subsides | |
| CN114177506B (en) | Medicine and light source composite treatment device | |
| CN115813746A (en) | Local oxygen therapy and phototherapy combined treatment cover | |
| CN215652540U (en) | Three oxygen therapy limbs treatment bag | |
| CN210673553U (en) | Breathable self-heating navel paste | |
| CN220344932U (en) | Medicine applying device for photodynamic therapy in anal canal | |
| CN203677728U (en) | Cancer pain treatment plaster | |
| CN113974972B (en) | Medical dressing | |
| CN218338744U (en) | Negative pressure drainage device for wound treatment | |
| CN221180813U (en) | Eye patch for eye treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |